The effects of new technologies and discoveries — from nuclear power to medical treatments — often must be inferred long before they are experienced, forcing policymakers to rely on risk, cost and benefit analyses when deciding whether to use them. A new article critically examines these analytical methods, considering how they should be used and how they can be abused.